Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002817HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10004347HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10002789HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10002790HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10022415HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10028611HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10022437HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10028612HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10022438HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TVIS10028613HBVENSG00000114982.19protein_codingKANSL3NoNo55683Q9P2N6
TCGA Plot Options
Drug Information
GeneKANSL3
DrugBank IDDB03467
Drug NameNaringenin
Target IDBE0009091
UniProt IDQ9P2N6
Regulation Type
PubMed IDs24412302
CitationsPriscilla DH, Roy D, Suresh A, Kumar V, Thirumurugan K: Naringenin inhibits alpha-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem Biol Interact. 2014 Mar 5;210:77-85. doi: 10.1016/j.cbi.2013.12.014. Epub 2014 Jan 8.
GroupsExperimental
Direct ClassificationFlavanones
SMILES[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Pathways
PharmGKBPA151958361
ChEMBLCHEMBL9352